SCHEMBL30890516

SCHEMBL30890516

[2H]N1CCC2(C1)Oc1ncc(C)cc1NC2=O

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 14/20 0.39
▸ MAP4K1 Q92918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22695464 0.84 OTUD7B (0.44) OTUD7BMAP4K1
SCHEMBL24307027 0.81 OTUD7B (0.42) OTUD7BMAP4K1
SCHEMBL30890588 0.76 OTUD7B (0.36) OTUD7B
SCHEMBL27244637 0.71 OTUD7B (0.33) OTUD7B
SCHEMBL20608116 0.69 OTUD7B (0.60) OTUD7B
SCHEMBL21352872 0.67 OTUD7B (0.44) OTUD7BMAP4K1
SCHEMBL27244749 0.67 OTUD7B (0.38) OTUD7B
SCHEMBL22803136 0.67 OTUD7B (0.41) OTUD7BMAP4K1
SCHEMBL30890770 0.67 LMNA (0.36) —
SCHEMBL30890782 0.66 PDE1A (0.33) OTUD7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback